🌎 Kroger Initiated, Albertsons Companies Initiated, Sportradar Group Initiated and more...

Ratings changes for Netflix, Kratos Defense & Security Solutions, CoreWeave, Blaize, United Airlines, Cass Information Systems, Amazon.com and more...Text "MarketBeat" to  68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports.  Learn More. Unsubscribe. View My Portfolio July 21st, 2025     Is Elon's empire crumbling? (ad) The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.   Click here to see the Tesla shock that could blindside everyone. Today's Top Stories 5 High-Risk, High-Reward Stocks With Serious Momentum By Ryan Hasson  |  July 21, 2025 09:10 AM The big winner of Crypto week?  (Ad) By Weiss Ratings Is China Investable Again? 2 Stocks Soaring as Tensions Ease By Dan Schmidt  |  July 21, 2025 08:59 AM Q2 Could Be the Catalyst PayPal Investors Have Been Waiting For By Sam Quirke  |  July 21, 2025 08:42 AM Jeff Bezos' honeymoon humiliation  (Ad) By Brownstone Research Companies pledge to invest more than $700 billion in Germany over the next 3 years By The Associated Press  |  July 21, 2025 08:16 AM More Americans shift money from checking and savings to accounts with investment income, study says By The Associated Press  |  July 21, 2025 08:00 AM Quick Links Analyst Ratings My MarketBeat Account Settings MarketBeat All Access Stock Lists Screener Calculators Premium Reports Buy Stock Jeff Bezos' honeymoon humiliation (ad) Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called "Bitcoin Skimming" to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.   Watch the Bitcoin Skimming strategy here Your Watchlist Manage Your Watchlist and Monitor Your Portfolio   Apple Inc. (AAPL) $213.61 +2.43 (+1.15%)  As of 7/21/2025 10:49 AM ET (7/21) Apple Needs to Leave Its 'Comfort Zone' on AI. Elon Musk Could Help. (barrons.com) (7/21) AAPL Investors Have Opportunity to Lead Apple Inc. Securities Fraud Lawsuit with the Schall Law Firm (prnewswire.com) (7/21) Apple Inc. (AAPL)'s "Got Game," Says Jim Cramer (finance.yahoo.com) (7/21) APPLE INC. (NASDAQ: AAPL) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Apple Inc. Investors of Upcoming Deadline (globenewswire.com) (7/21) Apple (NASDAQ:AAPL) Stock Unloaded Rep. Tim Moore (marketbeat.com)   Amazon.com, Inc. (AMZN) $227.89 +1.76 (+0.78%)  As of 7/21/2025 10:49 AM ET Amazon.com (NASDAQ:AMZN) had its price target raised by Robert W. Baird (    ) (analyst Colin Sebastian) from $220.00 to $244.00. They now have an "outperform" rating on the stock. This represents a 7.9% upside from the current price of $226.13. (7/21) Amazon Has A Tariff Problem, Automation May Be The Solution (seekingalpha.com) (7/21) NFLX, WBD and AMZN Forecast – US Major Stocks Look to Higher Levels (fxempire.com) (7/21) Amazon.com (NASDAQ:AMZN) Price Target Raised to $244.00 at Robert W. Baird (marketbeat.com) (7/21) Amazon Investors Search for Signs of AI Lift With Shares Lagging (finance.yahoo.com) (7/21) Beyond Market Price: Uncovering Amazon.com Inc's Intrinsic Value (gurufocus.com)   Alphabet Inc. (GOOGL) $189.30 +4.24 (+2.29%)  As of 7/21/2025 10:49 AM ET Alphabet (NASDAQ:GOOGL) will be releasing earnings after the market closes on Wednesday, July 23. (View Earnings Report) (7/21) Alphabet Set For Strong Q2 Earnings — But Analysts Warn: 'AI Search Remains Google's War To Lose' (benzinga.com) (7/21) Is China Investable Again? 2 Stocks Soaring as Tensions Ease (GOOGL) (marketbeat.com) (7/21) Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Computer and Technology Names (zacks.com) (7/21) Stocks Face a Trade Reckoning. Why Tesla, Google, Coca-Cola Earnings Are Key. (barrons.com) (7/21) Prediction: This Artificial Intelligence (AI) Stock Could Be the Biggest Winner of the Second Half of 2025 (fool.com)   Meta Platforms, Inc. (META) $714.15 +9.87 (+1.40%)  As of 7/21/2025 10:49 AM ET Meta Platforms (NASDAQ:META) had its price target raised by Morgan Stanley (    ) (analyst Brian Nowak) from $650.00 to $750.00. They now have an "overweight" rating on the stock. This represents a 5.1% upside from the current price of $713.84. (7/21) Meta investors settlement with Zuckerberg takes heat off Delaware (reuters.com) (7/21) Litman Gregory Wealth Management LLC Cuts Position in Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com) (7/21) Ascent Wealth Partners LLC Grows Holdings in Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com) (7/20) Prediction: This Artificial Intelligence (AI) Stock Could Hit a $2 Trillion Valuation by July 31 (fool.com) (7/20) Top Wall Street analysts are confident about the potential of these 3 stocks (cnbc.com)   Microsoft Corporation (MSFT) $510.86 +0.81 (+0.16%)  As of 7/21/2025 10:49 AM ET Microsoft (NASDAQ:MSFT) had its price target raised by Barclays PLC (    ) (analyst Raimo Lenschow) from $494.00 to $550.00. They now have an "overweight" rating on the stock. This represents a 7.4% upside from the current price of $511.93. (7/21) Microsoft (NASDAQ:MSFT) Given New $550.00 Price Target at Barclays (marketbeat.com) (7/21) Microsoft releases urgent fix for Sharepoint vulnerability being used in global cyberattacks (marketbeat.com) (7/21) Why Microsoft Is Urging Security Updates for SharePoint Customers (barrons.com) (7/21) Microsoft server software hit by widespread cyberattack (msn.com) (7/21) Microsoft Alerts Firms to Server Software Attack (msn.com) Manage Your Watchlist Analysts' Upgrades Aveanna Healthcare (NASDAQ:AVAH) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $6.00 price target on the stock, down previously from $6.25. This represents a 43.9% upside from the current price of $4.17. Blaize (NASDAQ:BZAI) was upgraded by analysts at Rosenblatt Securities from a "neutral" rating to a "buy" rating. They now have a $6.00 price target on the stock, up previously from $3.00. This represents a 13.0% upside from the current price of $5.31. CSX (NASDAQ:CSX) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $45.00 price target on the stock, up previously from $32.00. This represents a 30.6% upside from the current price of $34.46. Dollar Tree (NASDAQ:DLTR) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $138.00 price target on the stock, up previously from $95.00. This represents a 22.6% upside from the current price of $112.59. Etsy (NASDAQ:ETSY) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $50.00 price target on the stock, up previously from $38.00. This represents a 17.2% downside from the current price of $60.41. Fiserv (NYSE:FI) was upgraded by analysts at Monness Crespi & Hardt from a "sell" rating to a "neutral" rating.The current price is $165.87. Fortis (NYSE:FTS) was upgraded by analysts at CIBC from a "neutral" rating to a "sector outperform" rating.The current price is $47.89. Globant (NYSE:GLOB) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $115.00 price target on the stock. This represents a 34.6% upside from the current price of $85.46. Invesco (NYSE:IVZ) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $25.00 price target on the stock, up previously from $17.50. This represents a 23.4% upside from the current price of $20.26. Keysight Technologies (NYSE:KEYS) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $175.00 price target on the stock, up previously from $170.00. This represents a 6.7% upside from the current price of $164.06. Norfolk Southern (NYSE:NSC) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $323.00 price target on the stock, up previously from $263.00. This represents a 16.3% upside from the current price of $277.68. Pinterest (NYSE:PINS) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $45.00 price target on the stock, up previously from $37.00. This represents a 17.6% upside from the current price of $38.27. View More Upgrades Crypto Genius: Forget bitcoin – this will be so much bigger (ad) New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it's the first sign that "Trump's Great Gain" has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he's laying out the full gameplan in a new presentation.   See Altucher's Trump crypto prediction here Analysts' Downgrades American Express (NYSE:AXP) was downgraded by analysts at DZ Bank AG from a "hold" rating to a "sell" rating.The current price is $306.40. Krispy Kreme (NASDAQ:DNUT) was downgraded by analysts at BNP Paribas Exane from an "outperform" rating to a "neutral" rating. They now have a $3.50 price target on the stock. This represents a 11.3% upside from the current price of $3.15. Gaming and Leisure Properties (NASDAQ:GLPI) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating. They now have a $51.25 price target on the stock. This represents a 8.9% upside from the current price of $47.07. Sarepta Therapeutics (NASDAQ:SRPT) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $14.00 price target on the stock. This represents a 4.1% upside from the current price of $13.44. Sarepta Therapeutics (NASDAQ:SRPT) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating.The current price is $13.44. Sarepta Therapeutics (NASDAQ:SRPT) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating.The current price is $13.44. Telus Digital (NYSE:TIXT) was downgraded by analysts at National Bank Financial from an "outperform" rating to a "sector perform" rating. They now have a $4.00 price target on the stock. This represents a 0.1% upside from the current price of $4.00. Ternium (NYSE:TX) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $34.00 price target on the stock. This represents a 10.2% upside from the current price of $30.85. View More Downgrades Trump's betrayal exposed (ad) Trump's Final Reset Inside the shocking plot to re-engineer America's financial system…and why you need to move your money now.   Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma Analysts' New Coverage Albertsons Companies (NYSE:ACI) is now covered by analysts at Barclays PLC. They set an "underweight" rating and a $19.00 price target on the stock. This represents a 6.7% downside from the current price of $20.38. Autodesk (NASDAQ:ADSK) is now covered by analysts at Loop Capital. They set a "hold" rating and a $320.00 price target on the stock. This represents a 7.6% upside from the current price of $297.35. Argan (NYSE:AGX) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating and a $220.00 price target on the stock. This represents a 4.8% upside from the current price of $210.01. Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $385.00 price target on the stock. This represents a 19.9% upside from the current price of $321.21. The Arena Group (NYSE:AREN) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $10.00 price target on the stock. This represents a 78.1% upside from the current price of $5.61. AvePoint (NASDAQ:AVPT) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $22.00 price target on the stock. This represents a 13.8% upside from the current price of $19.33. BridgeBio Pharma (NASDAQ:BBIO) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $66.00 price target on the stock. This represents a 40.8% upside from the current price of $46.88. Biogen (NASDAQ:BIIB) is now covered by analysts at Truist Financial Corporation. They set a "hold" rating and a $142.00 price target on the stock. This represents a 16.6% upside from the current price of $121.78. Colliers International Group (NASDAQ:CIGI) (TSE:CIGI) is now covered by analysts at JMP Securities. They set a "market perform" rating on the stock.The current price is $139.19. Colliers International Group (NASDAQ:CIGI) (TSE:CIGI) is now covered by analysts at Citizens Jmp. They set a "market perform" rating on the stock.The current price is $139.19. Centessa Pharmaceuticals (NASDAQ:CNTA) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $30.00 price target on the stock. This represents a 89.3% upside from the current price of $15.85. Cushman & Wakefield (NYSE:CWK) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $15.00 price target on the stock. This represents a 30.4% upside from the current price of $11.51. Cushman & Wakefield (NYSE:CWK) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $15.00 price target on the stock. This represents a 30.4% upside from the current price of $11.51. eMagin (NYSE:EMA) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $49.00 price target on the stock. This represents a 7.3% upside from the current price of $45.66. Harmony Biosciences (NASDAQ:HRMY) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $48.00 price target on the stock. This represents a 34.3% upside from the current price of $35.74. Disc Medicine (NASDAQ:IRON) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $86.00 price target on the stock. This represents a 47.7% upside from the current price of $58.21. Jernigan Capital (NYSE:JCAP) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $23.00 price target on the stock. This represents a 37.7% upside from the current price of $16.70. Jernigan Capital (NYSE:JCAP) is now covered by analysts at Keefe, Bruyette & Woods. They set an "outperform" rating and a $22.00 price target on the stock. This represents a 31.7% upside from the current price of $16.70. Jernigan Capital (NYSE:JCAP) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $24.00 price target on the stock. This represents a 43.7% upside from the current price of $16.70. Jernigan Capital (NYSE:JCAP) is now covered by analysts at Raymond James Financial, Inc.. They set an "outperform" rating and a $19.00 price target on the stock. This represents a 13.8% upside from the current price of $16.70. Jernigan Capital (NYSE:JCAP) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $23.00 price target on the stock. This represents a 37.7% upside from the current price of $16.70. Jernigan Capital (NYSE:JCAP) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $29.00 price target on the stock. This represents a 73.7% upside from the current price of $16.70. Jones Lang LaSalle (NYSE:JLL) is now covered by analysts at Citizens Jmp. They set a "market perform" rating on the stock.The current price is $256.52. Jones Lang LaSalle (NYSE:JLL) is now covered by analysts at JMP Securities. They set a "market perform" rating on the stock.The current price is $256.52. John Marshall Bancorp (NASDAQ:JMSB) is now covered by analysts at Keefe, Bruyette & Woods. They set an "outperform" rating and a $22.00 price target on the stock. This represents a 13.7% upside from the current price of $19.35. Kroger (NYSE:KR) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $75.00 price target on the stock. This represents a 4.5% upside from the current price of $71.75. Centrus Energy (NYSE:LEU) is now covered by analysts at UBS Group AG. They set a "neutral" rating and a $215.00 price target on the stock. This represents a 11.5% downside from the current price of $242.98. Marcus & Millichap (NYSE:MMI) is now covered by analysts at JMP Securities. They set a "market perform" rating on the stock.The current price is $31.11. Marcus & Millichap (NYSE:MMI) is now covered by analysts at Citizens Jmp. They set a "market perform" rating on the stock.The current price is $31.11. Neurocrine Biosciences (NASDAQ:NBIX) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $163.00 price target on the stock. This represents a 23.4% upside from the current price of $132.08. Newmark Group (NASDAQ:NMRK) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $17.00 price target on the stock. This represents a 33.7% upside from the current price of $12.71. Newmark Group (NASDAQ:NMRK) is now covered by analysts at JMP Securities. They set a "market outperform" rating and a $17.00 price target on the stock. This represents a 33.7% upside from the current price of $12.71. Paylocity (NASDAQ:PCTY) is now covered by analysts at Stephens. They set an "equal weight" rating and a $200.00 price target on the stock. This represents a 8.7% upside from the current price of $184.01. Park National (NYSE:PRK) is now covered by analysts at Raymond James Financial, Inc.. They set a "market perform" rating on the stock.The current price is $171.10. Palvella Therapeutics (NASDAQ:PVLA) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $56.00 price target on the stock. This represents a 83.4% upside from the current price of $30.54. QXO (NASDAQ:QXO) is now covered by analysts at Royal Bank Of Canada. They set an "outperform" rating and a $33.00 price target on the stock. This represents a 50.4% upside from the current price of $21.94. Radiopharm Theranostics (NASDAQ:RADX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $18.00 price target on the stock. This represents a 308.2% upside from the current price of $4.41. Ralliant (NYSE:RAL) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $53.00 price target on the stock. This represents a 12.2% upside from the current price of $47.25. Sprouts Farmers Market (NASDAQ:SFM) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $173.00 price target on the stock. This represents a 3.4% upside from the current price of $167.31. SiriusPoint (NYSE:SPNT) is now covered by analysts at B. Riley. They set a "buy" rating and a $33.00 price target on the stock. This represents a 70.0% upside from the current price of $19.41. Sportradar Group (NASDAQ:SRAD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $31.00 price target on the stock. This represents a 3.9% upside from the current price of $29.83. ThredUp (NASDAQ:TDUP) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $9.00 price target on the stock. This represents a 14.9% upside from the current price of $7.83. Tectonic Therapeutic (NASDAQ:TECX) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating and a $64.00 price target on the stock. This represents a 188.7% upside from the current price of $22.17. Tenaris (NYSE:TS) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating on the stock.The current price is $37.23. View More New Coverage Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Earnings Conference Calls Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Stock Splits Unusual Options Volume Unusual Trading Volume Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. Upgrade Now Manage Your Watchlist View and add up to ten holdings to your watchlist. View My Portfolio Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. Join Now Thank you for subscribing to MarketBeat! MarketBeat empowers individual investors to make better trading decisions by delivering real-time financial information and unbiased investment research.   If you have questions about your newsletter, feel free to email MarketBeat's U.S. based support team at contact@marketbeat.com.   If you desire to unsubscribe or change which emails you receive, you can modify your email preferences or unsubscribe from this newsletter.   © 2006-2025 MarketBeat Media, LLC. 345 N Reid Place, Sixth Floor, Sioux Falls, S.D. 57103. USA..   Check This Out: The 7 Best Stocks to Own in Summer 2025 (Click to Opt-In)

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn

Subscribe to receive free email updates: